Method for eliciting an immune response to human telomerase reverse transcriptase
AssigneesGeron Corporation, The Regents of the University of Colorado
InventorsThomas R. Cech, Joachim Lingner, Toru M. Nakamura, Karen B. Chapman, Gregg B. Morin, Calvin B. Harley, William H. Andrews
Life of this patent
Estimating the term…
Abstract
The invention provides compositions and methods related to human telomerase reverse transcriptase (hTRT), the catalytic protein subunit of human telomerase. The polynucleotides and polypeptides of the invention are useful for diagnosis, prognosis and treatment of human diseases, for changing the proliferative capacity of cells and organisms, and for identification and screening of compounds and treatments useful for treatment of diseases such as cancers.
Claims4
A method for eliciting an immune response to human telomerase reverse transcriptase protein in a subject, comprising administering to the subject a composition comprising an immunogenic peptide and an adjuvant, wherein the peptide comprises 10 or more consecutive amino acids of SEQ. ID NO:2.
A method for eliciting an immune response to human telomerase reverse transcriptase protein in a subject, comprising administering to the subject a composition comprising an immunogenic peptide and an adjuvant, wherein the peptide comprises 8 or more consecutive amino acids of SEQ. ID NO:2, wherein a telomerase specific immune response is elicited.
Dependencies are inferred from the claim text.